Visiomed Group SA
PAR:ALVMG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Visiomed Group SA
Accounts Receivables
Visiomed Group SA
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Visiomed Group SA
PAR:ALVMG
|
Accounts Receivables
€1.2m
|
CAGR 3-Years
67%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-1%
|
|
|
Edap Tms SA
NASDAQ:EDAP
|
Accounts Receivables
€21.3m
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
7%
|
|
|
Biomerieux SA
PAR:BIM
|
Accounts Receivables
€766.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
|
S
|
SMAIO SA
PAR:ALSMA
|
Accounts Receivables
€1.7m
|
CAGR 3-Years
65%
|
CAGR 5-Years
65%
|
CAGR 10-Years
N/A
|
|
|
Amplitude Surgical SA
PAR:AMPLI
|
Accounts Receivables
€14.4m
|
CAGR 3-Years
4%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Mauna Kea Technologies SA
PAR:ALMKT
|
Accounts Receivables
€1.6m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-8%
|
|
Visiomed Group SA
Glance View
Visiomed Group SA engages in the development and distribution of healthcare products and services. The company is headquartered in Puteaux, Ile-De-France. The company went IPO on 2011-07-05. The firm is primarily engaged in the design, manufacture and marketing of medical electronics. The company develops and markets health products in the fields of medical and well-being self-diagnosis to provide non-drug prevention and treatment solutions. The firm's product portfolio comprises MyThermo, an infrared contact-less medical thermometer; MyTension, an automatic blood pressure and pulse monitors; MyOxy, a finger pulse oximeter; MyECG, a pocket electrodiogram; MyGluco, a blood sugar meter; My Coach, a health and fitness coach, and Epiderm, a telemedicine dermatology mobile application, among others. The firm serves pharmacies, health professionals, hospitals, clinics and retirement homes. The company also offers connected solutions and COVID devices such as deconfinement kits, masks, filter cushion, serological tests etc. The Company’s subsidiaries include ThermoFlash and BewellConnect.
See Also
What is Visiomed Group SA's Accounts Receivables?
Accounts Receivables
1.2m
EUR
Based on the financial report for Dec 31, 2023, Visiomed Group SA's Accounts Receivables amounts to 1.2m EUR.
What is Visiomed Group SA's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
-1%
Over the last year, the Accounts Receivables growth was -36%. The average annual Accounts Receivables growth rates for Visiomed Group SA have been 67% over the past three years , 4% over the past five years , and -1% over the past ten years .
